COMP <GO>
ASPI vs FCX // ALTMAN Z-SCORE & DEBT/EQUITY
ASP Isotopes Inc. (NASDAQ) VS. Freeport-McMoRan Inc. (NYSE) • 15-METRIC TALLY: ASPI 1
— FCX 10
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: FCX
LAST: $2.13 (+4.93%) • MKT CAP: $326.5M
balance-sheet
0.72
LAST: $66.14 (-0.69%) • MKT CAP: $94.98B
balance-sheet
3.08
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ASPI VS. FCX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ASPI | FCX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 14.30% | 26.10% | -11.80 | FCX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 21.50% | -56.50 | FCX | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 13.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -14.53% | 4.71% | -19.24 | FCX | /fcf-yield <GO> |
| Operating Margin | -60.00% | 25.90% | -85.90 | FCX | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 8.80% | -68.80 | FCX | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | 0.10% | +179.90 | ASPI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.91% | -0.91 | FCX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 0.72 | 3.08 | -2.36 | FCX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | FCX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.4 | 43.5 | -4.10 | FCX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.95 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 40.1x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $326.5M | $94.98B | -$94.65B | FCX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ASPI REV | FCX REV | ASPI GROSS % | FCX GROSS % | ASPI FCF | FCX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $23.8M | $25.19B | 14.3% | 26.1% | -$47.4M | $4.48B |
| FY 2024 | $4.1M | $25.17B | 38.6% | 29.3% | -$26.4M | $6.03B |
| FY 2023 | $433.0K | $22.70B | — | — | -$5.4M | $4.26B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ASPI // BETA —
FCX // BETA 0.95